Company Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform.
It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.
The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms.
The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses.
The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Contact Details
Address: 13 Gad Feinstein Street, Park Rehovot Rehovot, 7638517 Israel | |
| Phone | 972 8 931 1900 |
| Website | evogene.com |
Stock Details
| Ticker Symbol | EVGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001574565 |
| CUSIP Number | M4119S104 |
| ISIN Number | IL0011050551 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Amit Noam Capt. res. | Chief Executive Officer of Lavie Bio Ltd. |
| Dr. Dan Jacob Gelvan Ph.D. | Chief Executive Officer of Ag Plenus Ltd. |
| Yoash Zohar | Chief Executive Officer of Casterra Ag Ltd. |
| Dr. Elran Hillel Haber M.B.A., Ph.D. | Chief Executive Officer of Biomica Ltd |
| Ofer Haviv CPA | Chief Executive Officer, President and Director |
| Yaron Eldad | Chief Financial Officer |
| Liat Foigel Wejgman | Vice President of Human Resources |
| Russ Putland | Executive Vice President Commercial and General Manager USA |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 17, 2025 | 6-K | Report of foreign issuer |
| Jul 8, 2025 | 6-K | Report of foreign issuer |
| Jun 17, 2025 | 6-K | Report of foreign issuer |
| Jun 5, 2025 | 6-K | Report of foreign issuer |
| May 21, 2025 | 6-K | Report of foreign issuer |
| Apr 21, 2025 | 6-K | Report of foreign issuer |
| Apr 2, 2025 | EFFECT | Notice of Effectiveness |
| Mar 28, 2025 | POS AM | Post-Effective amendments for registration statement |
| Mar 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 27, 2025 | 20-F | Annual and transition report of foreign private issuers |